Hims & Hers shares rally on results, but execs say GLP-1 drug shortage ‘is not abating’




Shares of Hims & Hers Health Inc. rallied after hours on Monday after the wellness platform bumped its full-year sales forecast higher, as its efforts to offer more personalized care and more weight-loss drugs continue to draw subscribers.



Source link

Scroll to Top